
Piasclédine 300mg box of 60 capsules
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
This medicine contains a combination of plant extracts.
Medicine based on avocado and soya unsaponifiables indicated for the symptomatic treatment (pain and discomfort during movement) with a delayed effect of osteoarthritis of the knee (Requires a medical diagnosis).
PIASCLÉDINE 300 box of 30 capsules.
Also available in boxes of 60 capsules and 90 capsules
p capsules | |
Unsaponifiables of avocado oil | 100 mg |
Unsaponifiables of soybean oil | 200 mg |
Active ingredients: Unsaponifiables of avocado oil, Unsaponifiables of soya oil
Excipients: Butylated hydroxytoluene, Erythrosine, Yellow iron oxide, Gelatin, Polysorbate 80, Colloidal anhydrous silica, Titanium dioxide
The effect of this drug during pregnancy or lactation is not known. The evaluation of the possible risk related to its use is individual: ask your pharmacist or your doctor for advice.
The capsules should be swallowed with a glass of water, in the middle of meals.
1 capsule per day.
In the treatment of osteoarthritis, the effect of this medication is slow to appear: relief generally appears only after 1 to 2 months of treatment.
The drug treatment does not dispense with measures to fight against possible overweight. It is also recommended to practice an adapted physical activity to strengthen the muscles and maintain the mobility of the joint.
Rare regurgitation with a lipidic smell, allergic reaction.
Diarrhea, stomach pain.
Exceptionally: liver damage.
If you have experienced an adverse reaction that may be due to this medicine, you can report it by downloading the form.
See the Piascledine® 300 leaflet in the "Attached documents" tab
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Delayed-effect symptomatic treatment of osteoarthritis of the hip and knee.
1200 mg oral gel: Sachets, box of 30.
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.
Indicated in the symptomatic treatment of osteoarthritis.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Arthrum HCS 40mg/2ml is indicated for all types of painful synovial joint arthritis, particularly gonarthrosis.
Arthrum HCS is biologically similar to human synovial fluid and participates in the following functions: Protect the cartilage, Protect the synovial membrane, Reduce pain and improve mobility
Symptomatic treatment ofosteoarthritis.
Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.
1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid
Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.
COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.
COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.
COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM must be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist doctor, to relieve the pain associated with osteoarthritis of the hip.
SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.
The therapeutic indications are all types of painful gonarthrosis:
- Primary gonarthrosis (Kelgreen radiological stages I, II and III)
- Gonarthrosis and associated general factors:
- Ineffectiveness of usual treatments.
- Intolerance and/or contraindication to NSAIDs and/or analgesics.
- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).
- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.
- Early gonarthrosis in young patients.
- Gonarthrosis secondary to trauma and the aftermath of articular fractures.
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.